Amantadine-HCL treatment of chronic hepatitis C in non-responders to alpha-interferon.

被引：0
|
作者：
Parolin, MB [1 ]
Lacerda, MA [1 ]
Lopes, RW [1 ]
机构：
[1] Univ Fed Parana, Div Gastroenterol Hepatol, BR-80060000 Curitiba, Parana, Brazil
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2208
引用
收藏
页码：714A / 714A
页数：1
相关论文
共 50 条
  • [31] Pilot study of intron-a and ribavirin vs intron-a amantadine in interferon non-responders with chronic hepatitis
    Khalili, CM
    Olmeda, M
    Yantsos, VA
    Perrillo, RP
    GASTROENTEROLOGY, 1998, 114 (04) : A1271 - A1271
  • [32] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [33] Clinical outcome of chronic hepatitis C in patients treated with interferon: comparison between responders and non-responders
    Morisco, F
    Marmo, R
    Iasevoli, P
    Sessa, G
    Tuccillo, C
    Blanco, CD
    Caporaso, N
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 454 - 458
  • [34] Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha
    Leroy, V
    De Traversay, C
    Barnoud, R
    Hartmann, JD
    Baud, M
    Ouzan, D
    Zarski, JP
    JOURNAL OF HEPATOLOGY, 2001, 35 (01) : 120 - 126
  • [35] Interferon-α-2b+ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α-monotherapy
    Tromm, A
    Greving, I
    Griga, T
    Mankel, K
    Hüppe, D
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (02): : 159 - 164
  • [36] Interferon alpha2a in combination with lamivudine in the treatment of patients with chronic HBeAg(-) hepatitis B non-responders to interferon monotherapy
    Raptopoulou-Gigi, M
    Sinakos, E
    Orphanou, H
    Lalla, T
    JOURNAL OF HEPATOLOGY, 2002, 36 : 245 - 245
  • [37] Interferon induction treatment with and without amantadine HCl (AHCl) in patients with chronic hepatitis C
    Jorge, FA
    Tanno, H
    Igartua, EB
    Pinchuk, L
    Sorda, JA
    Curciarello, J
    Findor, A
    Isla, R
    Manero, E
    Bianchi, G
    Daruich, J
    JOURNAL OF HEPATOLOGY, 2001, 34 : 156 - 157
  • [38] Interferon treatment in children with chronic hepatitis C: Long-lasting remission in responders, and risk for disease progression in non-responders
    Bortolotti, F
    Iorio, R
    Nebbia, G
    Marcellini, M
    Giacchino, R
    Zancan, L
    Gussetti, N
    Barbera, C
    Maccabruni, A
    Verucchi, G
    Balli, F
    Vegnente, A
    Guido, M
    Bartolacci, S
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (05) : 336 - 341
  • [39] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
  • [40] Alpha-interferon plus ribavirin for the treatment of chronic hepatitis C in patients who have failed treatment with alpha-interferon.
    Kwo, PY
    Pound, DC
    Fields, S
    Glowinski, EA
    Chalasani, N
    Cho, WK
    Crabb, DW
    Cummings, OW
    Imperiale, T
    Lumeng, L
    McGill, JM
    Ness, R
    HEPATOLOGY, 1999, 30 (04) : 368A - 368A
12345